CD276 and hepatocellular carcinoma: Due to the importance of ICI in the immunotherapy of hepatocellular carcinoma, we further analyzed the differential expression of immune checkpoint genes between the two groups, and found that the expression in the low-risk group is higher, while the results for TNFSF4 and CD276 are the opposite (Figure 8A).